2017 Acura MDX Advance
3.5 L • V6 • 290 hp • 4×4 • AT
5FRYD4H94HB041261
Sales history: 1
• $9,200Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.5 L • V6 • 290 hp • 4×4 • AT
Odometer
64,365 mi ≈ 103,585 km
Primary damage
Rear end
Docs
TX • Cert Title
Extra
Auction
VIN
5FRYD4H94HB041261
Lot number
67681095
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Dallas, TX
Description
Fuel type
Gasoline
Body color
White
Body type
SUV
Generation
YD3, YD4
Trim
Advance
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
2017 Acura MDX Advance • 3.5 L • V6 • 290 hp • 4×4 • Automatic • Copart Lot: 67681095 • VIN: 5FRYD4H94HB041261
Find out more about this 2017 Acura MDX Advance, available at the Copart salvage car auction as lot 67681095 in Dallas, TX. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 64,365 mi. This White Acura MDX SUV is equipped with Gasoline 3.5 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for 5FRYD4H94HB041261 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
